Maker Is Pulling Controversial ALS Drug Relyvrio Off the Market

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market.In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed...